Bioceres Crop Solutions (BIOX) Cost of Revenue (2016 - 2026)

Bioceres Crop Solutions has reported Cost of Revenue for 11 years, with the latest figure at $26.7 million in Q1 2026.

• Quarterly Cost of Revenue fell 19.09% year-over-year to $26.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $164.5 million (down 26.14% YoY) and the FY2025 annual result came in at $203.4 million, down 26.88% from the prior year.
• Cost of Revenue declined to $26.7 million in Q1 2026 per BIOX's latest filing, from $47.2 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $88.7 million in Q4 2023 and troughed at $10.2 million in Q2 2022.
• A 5-year average of $51.8 million and a median of $49.3 million in 2025 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue plunged 99.94% in 2022, then jumped 534.84% in 2023.
• Over 5 years, Cost of Revenue stood at $59.1 million in 2022, then soared by 50.0% to $88.7 million in 2023, then plunged by 35.45% to $57.3 million in 2024, then declined by 17.65% to $47.2 million in 2025, then plunged by 43.38% to $26.7 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $26.7 million, $47.2 million, and $41.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.